The biotech industry is expected to face surprises and challenges in the new year, including the potential impact of Donald Trump’s second term and financial strain on startups due to economic projections. Despite this, trends like looking outside the U.S. for innovation and the growth of certain drugs for various conditions are expected to persist. Three major themes to watch for in 2025 include inventors’ interest in new molecules, the potential leadership of health agencies, and the impact of inflation and interest rates on financial strain.
Source link